In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker.

In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker.

One of the research challenges in oncology is to develop new biochemical methods for noninvasive tumor therapy evaluation to determine whether the chemotherapeutics is effective. Vascular endothelial growth factor (VEGF) was labeled with radioiodine and evaluated in vitro as well as in vivo, using A...

Full description

Bibliographic Details
Main Authors:	Cornelissen, B, Oltenfreiter, R, Kersemans, V, Staelens, L, Frankenne, F, Foidart, J, Slegers, G
Format:	Journal article
Language:	English
Published:	2005

Similar Items

Radiosynthesis and in vivo evaluation of 123I-rTIMP-2 as potential SPECT tumour imaging agent
by: Oltenfreiter, R, et al.
Published: (2004)

Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents.
by: Oltenfreiter, R, et al.
Published: (2006)

123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction
by: Cornelissen, B, et al.
Published: (2004)

In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
by: Kersemans, V, et al.
Published: (2005)

In vivo evaluation of [I-123]-2-Iodo-D-Phenylalanine in tumour inoculated athymic mice by means of SPECT as a potential diagnostic and radionuclide therapy tool.
by: Kersemans, V, et al.
Published: (2004)

Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
by: Kersemans, V, et al.
Published: (2006)

Synthesis of [I-123]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno[3,4-c]pyridin-5-one, a potential dopamine D4 ligand for SPECT studies
by: Staelens, L, et al.
Published: (2005)

In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
by: Kersemans, V, et al.
Published: (2005)

In vivo characterization of [123I]-2-Iodo-L-Phenylalanine in growing R1M rabdomyosarcoma bearing athymic mice as a potential tumour tracer for SPECT
by: Kersemans, V, et al.
Published: (2004)

Comparison between 1 T MRI and non-MRI based volumetry in inoculated tumours in mice.
by: Cornelissen, B, et al.
Published: (2005)

Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF165 Neutralization
by: Tanya A. Camacho-Villegas, et al.
Published: (2018-03-01)

Expression of VEGF165 and VEGF165b during ovarian follicular development
by: Chinnarat Changsangfa, et al.
Published: (2023-01-01)

A rapid in vivo diagnostical assay to assess the effect of a farnesyl transferase inhibitor on lovo cells using I-123-hEGF
by: Cornelissen, B, et al.
Published: (2003)

Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.
by: Kersemans, V, et al.
Published: (2006)

Detection of various tumour types in athymic mice with [123I]-2-Iodo-L-Phenylalanine and planar gamma camera acquisition
by: Kersemans, V, et al.
Published: (2004)

The splicing factor YBX1 promotes the progression of osteosarcoma by upregulating VEGF165 and downregulating VEGF165b
by: Bingxuan Quan, et al.
Published: (2023-08-01)

Highly Sensitive Electrochemical Aptasensor for Detecting the VEGF<sub>165</sub> Tumor Marker with PANI/CNT Nanocomposites
by: Yunjeong Park, et al.
Published: (2021-04-01)

123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice.
by: Kersemans, V, et al.
Published: (2006)

Use of [123I]-2-iodo-L-phenylalanine as a tumor imaging agent in two dogs with synovial cell sarcoma.
by: Peremans, K, et al.
Published: (2007)

The role of VEGF165B in pituitary adenomas pathogenesis
by: Eugen Melnic
Published: (2017-06-01)

123I-EGF uptake in tumours predicts long-term farnesyltransferase therapy outcome in athymic mice
by: Cornelissen, B, et al.
Published: (2004)

VEGF, VEGF165b and EG-VEGF expression is specifically related with hormone profile in pituitary adenomas
by: Ana Silvia Corlan, et al.
Published: (2019-03-01)

Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor.
by: Cornelissen, B, et al.
Published: (2005)

Expression of VEGF<sub>165</sub> and VEGF<sub>165b</sub> in human retinal pigment epithelial cells in hypoxia and high glucose environment
by: Ya-Jing Niu, et al.
Published: (2018-02-01)

In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
by: Burvenich, I, et al.
Published: (2005)

Gene therapy with VEGF 165 for angiogenesis in experimental acute myocardial infarction Terapia gênica com VEGF 165 para angiogênese no infarto agudo do miocárdio experimental
by: Roberto T. Sant'Anna, et al.
Published: (2003-06-01)

The Ionophoric Activity of a Pro-Apoptotic VEGF165 Fragment on HUVEC Cells
by: Stefania Zimbone, et al.
Published: (2020-04-01)

Development of a Multiplex Sandwich Aptamer Microarray for the Detection of VEGF165 and Thrombin
by: Anna Meneghello, et al.
Published: (2013-10-01)

VEGF-A165 is the predominant VEGF-A isoform in platelets, while VEGF-A121 is abundant in serum and plasma from healthy individuals.
by: Munekazu Yamakuchi, et al.
Published: (2023-01-01)

Cell penetrating peptides for in vivo molecular imaging applications.
by: Kersemans, V, et al.
Published: (2008)

Synthesis and assessment of [11C]acetylhomotaurine as an imaging agent for the study of the pharmacodynamic properties of acamprosate by positron emission tomography.
by: Courtyn, J, et al.
Published: (2004)

Estimation of systemic distribution and angiogenic effect of pl-VEGF165 in the model of limb ischemia
by: М. А. Юдин, et al.
Published: (2016-01-01)

Assessment of cone survival in response to CNTF, GDNF, and VEGF165b in a novel ex vivo model of end-stage retinitis pigmentosa.
by: Lipinski, D, et al.
Published: (2011)

Angiogenesis and bone regeneration of porous nano-hydroxyapatite/coralline blocks coated with rhVEGF165 in critical-size alveolar bone defects in vivo
by: Du B, et al.
Published: (2015-03-01)

Histopathological study of the effect of sunitinib in treatment of retinal angiogenesis induced by VEGF 165 in rabbits’eyes
by: Shahad Salah Aldeen, et al.
Published: (2018-12-01)

An Ensemble Docking Approach for Analyzing and Designing Aptamer Heterodimers Targeting VEGF<sub>165</sub>
by: Yeon Ju Go, et al.
Published: (2024-04-01)

Heparin-Induced Changes of Vascular Endothelial Growth Factor (VEGF<sub>165</sub>) Structure
by: Ekaterina L. Nemashkalova, et al.
Published: (2023-01-01)

Selective binding of C-6 OH sulfated hyaluronic acid to the angiogenic isoform of VEGF165
by: Lim, Dong-Kwon, et al.
Published: (2022)

Development and Characterization of VEGF165-Chitosan Nanoparticles for the Treatment of Radiation-Induced Skin Injury in Rats
by: Daojiang Yu, et al.
Published: (2016-10-01)

Selective binding of C-6 OH sulfated hyaluronic acid to the angiogenic isoform of VEGF165
by: Lim, Dong-Kwon, et al.
Published: (2021)